Loading data
EPRXNasdaq
| Unit: USD | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0 USD | 0 USD |
| Cost of revenue | 0 USD | 0 USD |
| Gross profit | 0 USD | 0 USD |
| Research and development expense | 21.33 m USD | 16.08 m USD |
| Selling, general and administrative expense | 38.27 m USD | 26.89 m USD |
| Operating profit after depreciation | -38.44 m USD | -27 m USD |
| Operating profit before depreciation | -38.27 m USD | -26.89 m USD |
| EBIT | -38.44 m USD | -27 m USD |
| EBITDA | -38.27 m USD | -26.89 m USD |
| Interest expense | 0 USD | 604 k USD |
| Profit before tax | -38.59 m USD | -25.74 m USD |
| Income tax expense | 19 k USD | 2 k USD |
| Income before extraordinary items | -38.58 m USD | -25.5 m USD |
| Net income (reported basis) | -38.58 m USD | -25.5 m USD |
| Basic EPS including extraordinary items | -1.03 USD/share | -0.76 USD/share |
| Diluted EPS including extraordinary items | -1.03 USD/share | -0.76 USD/share |
| Common dividends | 0 USD | 0 USD |
| Total dividends | 2.53 m USD | 425 k USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.